If the above hypothesis, which is not completely improbable, were true - why go with the placement with GF for Stage 3 expansion funding? They got a very good deal on the placement. As others have stated, perhaps that was the trade-off for renegotiation of the pricing formula? Given the pricing formula was never disclosed (and labelled confidential), renegotiation of it would not theoretically trigger a market sensitive announcement. In addition, the short selling is not specific to PLS, but a sector wide phenomenon. They are clearly betting on the macro rather than the micro.
If the above hypothesis, which is not completely improbable,...
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.16 |
Change
-0.030(0.94%) |
Mkt cap ! $9.516B | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.19 | $3.06 | $50.14M | 15.97M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49357 | $3.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.17 | 74794 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PLS (ASX) Chart |